Eosinophilic Esophagitis Diagnosis and Treatment
A biopsy showing 30 intraepithelial eosinophils per high-power field indicates eosinophilic esophagitis (EoE), and you should initiate treatment with swallowed topical corticosteroids as first-line therapy, with proton pump inhibitors (PPIs) or elimination diets as alternative options. 1, 2
Diagnostic Interpretation
Your patient meets the diagnostic threshold for EoE. The international consensus criteria establish that ≥15 eosinophils/hpf is the minimum diagnostic threshold 2, and your finding of 30 eos/hpf clearly exceeds this cutoff. This diagnosis requires:
- Symptoms of esophageal dysfunction (dysphagia, food impaction, chest pain, or GERD-like symptoms in adults; feeding difficulties or vomiting in children)
- Exclusion of other causes of esophageal eosinophilia through comprehensive assessment
- The presence of intraepithelial eosinophilia on biopsy
Critical update: The PPI trial is no longer required for diagnosis 2. Previous guidelines mandated ruling out "PPI-responsive esophageal eosinophilia" before diagnosing EoE, but this distinction has been abandoned because PPIs are now recognized as a legitimate treatment for EoE itself, not merely a diagnostic tool.
Treatment Algorithm
First-Line Therapy
Swallowed topical corticosteroids receive the only strong recommendation from the AGA guidelines 1. Options include:
- Fluticasone propionate (swallowed, not inhaled)
- Budesonide viscous suspension
These medications directly target the esophageal inflammation and have the strongest evidence base for efficacy.
Alternative First-Line Options (Conditional Recommendations)
Proton pump inhibitors: High-dose PPI therapy (e.g., omeprazole 40 mg twice daily or equivalent) for 8 weeks 1, 2. PPIs work through anti-inflammatory mechanisms beyond acid suppression and can effectively reduce esophageal eosinophilia in many patients.
Elimination diets: Either empiric elimination (removing common triggers like dairy, wheat, eggs, soy, nuts, seafood) or targeted elimination based on allergy testing 1, 3, 4
Treatment Selection Strategy
Start with swallowed topical corticosteroids unless:
- Patient prefers to avoid steroids → trial PPI first
- Strong suspicion of food triggers or patient preference for dietary approach → elimination diet
- Concurrent GERD symptoms → PPI may address both conditions
Monitoring and Treatment Goals
Target histologic response: <15 eosinophils/hpf 1. This threshold defines adequate therapeutic response, though the optimal target continues to be refined.
Repeat endoscopy with biopsy after initial therapy is reasonable to assess treatment response 1. The timing varies based on:
- Severity of initial presentation
- Treatment modality chosen
- Symptom response
Important caveat: Symptoms may not correlate with histologic activity 4, 5. Patients can remain symptomatic despite histologic improvement due to underlying fibrosis or neuromuscular dysfunction not visible on superficial biopsies. Conversely, some patients become asymptomatic while maintaining elevated eosinophil counts.
Additional Considerations
Biopsy Technique
Multiple biopsies (2-4 from both proximal and distal esophagus) are essential because EoE has patchy distribution 6, 7. Your single finding of 30 eos/hpf is diagnostic, but comprehensive sampling improves detection sensitivity.
Structural Complications
If dysphagia persists despite medical therapy or if strictures are present endoscopically, esophageal dilation is indicated 1. This addresses fibrostenotic changes that don't respond to anti-inflammatory treatment alone.
Long-Term Management
EoE is a chronic, relapsing disease. Maintenance therapy is typically required to prevent:
- Recurrent symptoms
- Progressive esophageal remodeling
- Stricture formation
- Food impactions
The specific maintenance regimen should be determined after assessing initial treatment response 1, 6.
Allergy Evaluation
Consider referral to allergist for comprehensive evaluation, particularly if pursuing dietary therapy, though allergy testing has limited ability to predict specific food triggers in EoE 4, 7.